Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Colonic Neoplasms × Anticoagulants × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1 Colonic Neoplasms 1 Adenocarcinoma 1

Interventions

tucatinib 1 trifluridine tipiracil drug combination 1 Trastuzumab 1 Specimen Handling 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1 Anticoagulants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00443573 2008-05-07

Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer

ARCA Biopharma, Inc.

Phase 1/2 Suspended

Gastrointestinal

Adenocarcinoma, Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡